(Press-News.org) Promising ovarian cancer research by Melanie Rutkowski, PhD, at the University of Virginia Comprehensive Cancer Center has won $700,000 in support from the Victoria’s Secret Global Fund for Women’s Cancers in partnership with Pelotonia and AACR, the American Association for Cancer Research.
Rutkowski has been selected as a Victoria’s Secret Rising Innovator, receiving a Research Grant in partnership with Pelotonia and AACR to further her studies of the role of the microbiome – the collection of microorganisms that live within us – in ovarian cancer and in the disease’s stubborn ability to resist immune therapy. Her work is shedding important light on understanding why ovarian cancer is so difficult to treat with immune therapies and could lead to better treatments to improve patient outcomes.
“It is such a tremendous honor to be selected as one of the recipients for the Victoria’s Secret Global Fund for Women’s Cancer Rising Innovator Research Grant,” said Rutkowski, part of the Department of Microbiology, Immunology and Cancer Biology at the UVA School of Medicine. “Most studies focus on how tumor cells drive resistance to immune therapy. Our lab has identified a pathway that is driven by our immune cells when they recognize commensal bacteria. However, we do not fully understand why these interactions have such a negative effect on the immune system.”
The Microbiome and Ovarian Cancer
The three-year grant will support Rutkowski’s investigations into how faulty cellular signaling undercuts the body’s ability to detect and fight off ovarian cancer. She has found that bacteria in the gut interact with particular immune cells to suppress the body’s immune response. This ultimately leads to the failure of immunotherapies designed to bolster that immune response and help the body destroy the cancer cells.
With the Victoria’s Secret grant money, Rutkowski aims to better understand how chronic exposure to the microbiome affects immune cells and the “microenvironment” that surrounds ovarian tumors. This microenvironment includes immune cells, blood vessels and other substances that can, collectively, either encourage or stifle cancer growth.
Rutkowski hopes her work will lead to ways to counter the effects of the faulty cellular signaling and, ultimately, enhance the effectiveness of immunotherapy for ovarian cancer.
“This grant will help us understand how and why these interactions lead to immune therapy failure, moving us a step closer to developing novel therapeutic interventions that enhance the immune system’s ability to kill cancer cells for patients with ovarian cancer,” Rutkowski said. “Outcomes for ovarian cancer are dismal, and immune therapy has the potential to offer a significant therapeutic benefit if we could figure out how to block the central pathways that drive resistance. The goal will be to use the discoveries from this award to eventually develop a novel immune therapy that can reinvigorate the immune system and ultimately improve outcomes for ovarian cancer.”
About the Grant
The Victoria’s Secret Fund for Women’s Cancers Rising Innovator Research Grant, in partnership with Pelotonia and AACR, supports midcareer scientists performing innovative research in breast and gynecological cancers. It seeks to foster innovation in the understanding, prevention, early detection, diagnosis and treatment of these cancers, with the goal of improving outcomes and eliminating cancer health disparities. The latest class of grant recipients is available on the AACR’s website.
Finding new and better ways to treat the most complex and challenging diseases is a primary mission for UVA’s new Paul and Diane Manning Institute of Biotechnology. The institute aims to accelerate how quickly lab discoveries can be translated into lifesaving new treatments for patients.
UVA’s commitment to enhancing the effectiveness of cancer immunotherapy – and the institution’s long history of success with therapeutic applications for focused ultrasound – have also prompted UVA Health to launch the world’s first Focused Ultrasound Cancer Immunotherapy Center. The center is exploring how combining immunotherapy with focused sound waves could improve immunotherapy effectiveness and revolutionize care for many different cancers.
To keep up with the latest medical research news from UVA, subscribe to the Making of Medicine blog at http://makingofmedicine.virginia.edu.
END
Victoria’s Secret grant backs cutting-edge ovarian cancer research
2026-01-08
ELSE PRESS RELEASES FROM THIS DATE:
Research paves the way for safer colonoscopy bowel prep for people with compromised gut health
2026-01-08
New preclinical research suggests that bowel preparation procedures for colonoscopies may temporarily alter gut balance, culminating in unappreciated effects in patients with compromised gastrointestinal health.
The study, published in Cell Reports Medicine, found that simulating bowel preparation in mouse models disrupted the gut environment, making the mice more susceptible to infection and inflammation.
"Colonoscopies play a crucial role in the diagnosis and treatment of gastrointestinal pathologies, including cancer, so it’s important to emphasize that we’re not trying ...
JMIR Publications and Sweden's National Library announce renewal and expansion of flat-fee unlimited open access partnership for 2026
2026-01-08
(Toronto & Stockholm, January 7, 2026) JMIR Publications, a leading open-access digital health research publisher, and the National Library of Sweden (NLS), representing the Bibsam Consortium, are pleased to announce the extension of their Flat-Fee Unlimited Open Access Publishing Agreement through December 31, 2026.
The renewal of this agreement, originally set to expire on December 31, 2025, reinforces the commitment of Swedish research funders and institutions to the principles of open science. The partnership provides authors affiliated with ...
A new 3D-printed solar cell that’s transparent and color-tunable
2026-01-08
A new study highlights a semi-transparent, color-tunable solar cell designed to work in places traditional panels can’t, like windows and flexible surfaces. Using a 3D-printed pillar structure, the researchers can fine-tune how much light passes through and what color the cell appears, without changing the solar material itself. The result is a system that balances energy output with durability, while giving designers far more control over how the technology looks and functions.
[Hebrew University of Jerusalem] The research was led by Prof. Lioz Etgar and Prof. Shlomo Magdassi and from the Institute of Chemistry and the Center for Nanoscience and Nanotechnology ...
IV iron is the cost-effective treatment for women with iron deficiency anemia and heavy menstrual bleeding
2026-01-08
(WASHINGTON, Jan. 8, 2026) — A single dose of intravenous (IV) iron dextran is the cost-effective treatment for women with heavy menstrual bleeding and iron deficiency anemia (IDA), according to new research published in Blood Advances.
“Oral iron is usually given as first-line treatment because on the surface, it appears less expensive and more convenient,” said study author Daniel Wang, a fourth-year medical student at Yale School of Medicine currently pursuing a research year as a recipient of the American Society of Hematology Medical Student Physician-Scientist Award. “However, we found that the preferred first-line treatment for these patients ...
Doing good pays off: Environmentally and socially responsible companies drive value and market efficiency
2026-01-08
Fukuoka, Japan—This year marks the 20th anniversary of the Principles for Responsible Investment (PRI), launched with United Nations backing in 2006. Today, environmental, social, and governance (ESG) related non-financial information—such as greenhouse gas emissions, pollution control, and diversity metrics—is routinely analyzed alongside traditional financial data.
As companies scale up their ESG commitments, core questions remain: do these efforts create extra value, and how do they ...
City of Hope and Cellares to automate manufacturing of solid tumor CAR T cell therapy
2026-01-08
Collaboration focuses on City of Hope’s IL13RA2-EGFR targeting CAR T cell program addressing a type of fast-growing, aggressive brain cancer called glioblastoma multiforme.
The collaboration addresses solid tumor manufacturing bottlenecks and accelerates advancement toward clinical trials.
Los Angeles and South San Francisco, Calif. – City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, and Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a ...
Short-circuiting pancreatic cancer
2026-01-08
Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It’s also the most common form of the disease. Potential treatments typically target a key mutated oncogene called KRAS. In some cases, PDAC tumors with these mutations have resisted therapeutic efforts. However, combination therapies involving alternative drug targets may one day help clinicians overwhelm these defenses.
In 2023, Cold Spring Harbor Laboratory (CSHL) Professor Adrian Krainer’s lab discovered ...
Groundbreaking mapping: how many ghost particles all the Milky Way’s stars send towards Earth
2026-01-08
They’re called ghost particles for a reason. They’re everywhere – trillions of them constantly stream through everything: our bodies, our planet, even the entire cosmos – without us noticing. These so-called neutrinos are elementary particles that are invisible, incredibly light, and interact only rarely with other matter. The weakness of their interactions makes neutrinos extremely difficult to detect. But when scientists do manage to capture them, they can offer extraordinary insights into the universe.
Neutrinos ...
JBNU researchers propose hierarchical porous copper nanosheet-based triboelectric nanogenerators
2026-01-08
In recent years, two-dimensional (2D) single-crystalline metal nanosheets have emerged as a promising next-generation platform for self-powered electronics. However, their potential for triboelectric nanogenerators (TENGs)—a promising energy-harvesting technology—remains largely untapped, mainly due to their low current output and limited durability.
In an innovative breakthrough, a team of researchers led by Associate Professor Tae-Wook Kim from the Department of Flexible and Printable Electronics, Jeonbuk National University, Republic of Korea, has redesigned the internal structure of 2D metal nanosheets to overcome the existing ...
A high-protein diet can defeat cholera infection
2026-01-08
Cholera, a severe bacterial infection that causes diarrhea and kills if untreated, can be defeated with a diet high in protein, according to a new study from UC Riverside.
Specifically, the study found that diets high in casein, the main protein in milk and cheese, as well as wheat gluten, could make a dramatic difference in the amount of cholera bacteria able to infect the gut.
“I wasn’t surprised that diet could affect the health of someone infected with the bacteria. But the magnitude of the effect surprised me,” said Ansel Hsiao, UCR associate professor of microbiology and plant pathology and senior author of the study published in Cell Host ...